| 1 | [SID56462793] | Active | EC50 | 0.385 | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction [AID435023, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Active | | EC50 | 0.385 [uM] | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 435023 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 2 | [SID56462793] | Active | Potency | 19.9526 | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID485290, Type: confirmatory] | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) | | AID | 485290 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] | | PubMed | | | Data Table |  |
|
| 3 | [SID17389890] | Active | Potency | 66.8242 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Active | | Potency | 66.8242 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 4 | [SID17389890] | Active | Potency | 66.8242 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Active | | Potency | 66.8242 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 5 | [SID17389890] | Active | Potency | 66.8242 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Active | | Potency | 66.8242 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 6 | [SID17389890] | Active | Potency | 66.8242 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Active | | Potency | 66.8242 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 7 | [SID48413744] | Active | | | DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity [AID1194, Type: other] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 48413744 | | CID | 6295 | | Outcome | Active | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity | | AID | 1194 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID56462793] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 9 | [SID56462793] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 10 | [SID56462793] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 11 | [SID56462793] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 12 | [SID56462793] | Active | | | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction [AID2629, Type: screening] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Active | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 2629 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 13 | [SID103688794] | Unspecified | | | Hepatotoxicity in mouse assessed as carcinogenic potency [AID433903, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103688794 | | CID | 6295 | | Outcome | Unspecified | | BioAssay | Hepatotoxicity in mouse assessed as carcinogenic potency | | AID | 433903 | | BioAssay type | Literature | | Target | | | PubMed | 19272677 | | Data Table |  |
|
| 14 | [SID17389890] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID56462793] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 16 | [SID56462793] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 17 | [SID17389890] | Inactive | Potency | 1.5849 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Inactive | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 18 | [SID17389890] | Inactive | Potency | 1.5849 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Inactive | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 19 | [SID17389890] | Inactive | Potency | 1.5849 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Inactive | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 20 | [SID56462793] | Inactive | Potency | 8.9125 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID17389890] | Inactive | Potency | 31.6228 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 22 | [SID17389890] | Inactive | Potency | 31.6228 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 23 | [SID17389890] | Inactive | Potency | 31.6228 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 24 | [SID56462793] | Inactive | Potency | 31.6228 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 25 | [SID56462793] | Inactive | Potency | 31.6228 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 26 | [SID56462793] | Inactive | Potency | 50.1187 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 27 | [SID56462793] | Inactive | Potency | 56.2341 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | 56.2341 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 28 | [SID56462793] | Inactive | Potency | 56.2341 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 29 | [SID56462793] | Inactive | Potency | 89.1251 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 30 | [SID56462793] | Inactive | Potency | 89.1251 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 31 | [SID56462793] | Inactive | Potency | | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 32 | [SID56462793] | Inactive | Potency | | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 33 | [SID56462793] | Inactive | Potency | | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 34 | [SID56462793] | Inactive | Potency | | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 35 | [SID56462793] | Inactive | | | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493012, Type: screening] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | BioAssay | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493012 | | BioAssay type | screening | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 36 | [SID56462793] | Inactive | Potency | | qHTS for Inhibitors of Vif-A3G Interactions: qHTS [AID602310, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3G Interactions: qHTS | | AID | 602310 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 37 | [SID56462793] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 38 | [SID56462793] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 39 | [SID56462793] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 40 | [SID56462793] | Inactive | | | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase [AID2805, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase | | AID | 2805 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 41 | [SID56462793] | Inactive | | | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase [AID2806, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase | | AID | 2806 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 42 | [SID56462793] | Inactive | Potency | | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504466, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504466 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 43 | [SID56462793] | Inactive | Potency | | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 44 | [SID56462793] | Inactive | | | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) [AID493160, Type: screening] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) | | AID | 493160 | | BioAssay type | screening | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 45 | [SID56462793] | Inactive | | | uHTS Fluorescent assay for identification of activators of hexokinase domain containing I (HKDC1) [AID493187, Type: screening] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent assay for identification of activators of hexokinase domain containing I (HKDC1) | | AID | 493187 | | BioAssay type | screening | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 46 | [SID17389890] | Inactive | Potency | | qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium [AID1457, Type: confirmatory] | Inositol monophosphatase [gi:44888968] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium | | AID | 1457 | | BioAssay type | confirmatory | | Target | Inositol monophosphatase [gi:44888968] | | PubMed | | | Data Table |  |
|
| 47 | [SID17389890] | Inactive | Potency | | qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium [AID1457, Type: confirmatory] | Inositol monophosphatase [gi:44888968] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium | | AID | 1457 | | BioAssay type | confirmatory | | Target | Inositol monophosphatase [gi:44888968] | | PubMed | | | Data Table |  |
|
| 48 | [SID17389890] | Inactive | Potency | | qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway [AID651751, Type: confirmatory] | pregnane X receptor [Rattus norvegicus] [gi:5702233] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17389890 | | CID | 6295 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway | | AID | 651751 | | BioAssay type | confirmatory | | Target | pregnane X receptor [Rattus norvegicus] [gi:5702233] | | PubMed | | | Data Table |  |
|
| 49 | [SID56462793] | Inactive | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 50 | [SID56462793] | Inactive | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56462793 | | CID | 6295 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|